US2014275843A1PendingUtilityA1
Continuous optode fluorescent measurement system
Individually held — no corporate assignee on recordPriority: Mar 15, 2013Filed: Mar 14, 2014Published: Sep 18, 2014
Est. expiryMar 15, 2033(~6.6 yrs left)· nominal 20-yr term from priority
A61B 5/14532A61B 5/14546A61B 2562/0285A61B 5/14556
36
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Presently described are systems and methods for the continuous, accurate, low cost measurement of the concentration of target molecule(s), e.g., analytes, such as metabolites and ions, using analyte-specific, light-emitting agents, e.g., fluorescent nanosensors.
Claims
exact text as granted — not AI-modified1 . An optical sensor (optode) system comprising:
(i) at least one analyte-specific, light-emitting agent, which emits light in the presence of the analyte; (ii) a sensor device configured to detect non-invasively the light emitted by the agent, the sensor device comprising a plurality of LEDs, at least one photodiode configured to detect light emitted from the light-emitting agent, an SOC/microprocessor, and transceiver to receive/transmit data wirelessly and, optionally, a photodiode light filter; and (iii) a display, wherein the system is configured such that the sensor quantifies the in vivo levels or concentration of the analyte and displays the information graphically on the display.
2 . The system of claim 1 , wherein the sensor device comprises two LEDs.
3 . The system of claim 1 , wherein the LEDs are located near or in apposition to the photodiode or window thereof.
4 . The system of claim 1 , wherein the sensor device further comprises an OpAmp, an ADC, an encrypted memory or a combination thereof.
5 . The system of claim 1 , wherein the display is a hand-held device display or a computer data website or both.
6 . The system of claim 1 , wherein the analyte is selected from the group consisting of glucose, sodium, potassium, calcium, chloride, and a combination thereof.
7 . The system of claim 1 , wherein the system is further configured to acquire continuous real-time measurement of the analyte concentration.
8 . The system of claim 1 , further comprising a drug delivery device in communication with the sensor.
9 . The system of claim 1 , further comprising at least one additional sensor which detects or measures a vital sign in a subject, wherein the vital sign is blood pressure, heart rate, temperature or a combination thereof.
10 . A method of monitoring an analyte in a patient non-invasively comprising the steps of:
administering an analyte-specific, light-emitting agent, which emits light in the presence of the analyte; providing an optical sensor system comprising a sensor device comprising a plurality of LEDs, at least one photodiode configured to detect light emitted from the light-emitting agent, an SOC/microprocessor, a transceiver for receiving/transmitting data wirelessly, and a display, wherein the sensor device is configured to detect and measure non-invasively the light emitted by the agent, calculate the amount or concentration of analyte present; detecting and measuring the intensity of light emitted by the analyte-specific light-emitting agent over a predetermined time course with the sensor device, wherein the sensor device calculates the amount or concentration of analyte present based on the intensity of light emitted by the light-emitting agent over the predetermined time course; transmitting the light emission data to a second processor having a display; displaying graphically the amount or concentration of the analyte detected by the sensor device over the predetermined time course.
11 . The method of claim 10 , wherein the sensor device comprises LEDs.
12 . The method of claim 12 , wherein the LEDs emit light at about 460 nm.
13 . The method of claim 10 , wherein the analyte is selected from the group consisting of glucose, sodium, potassium, calcium, chloride, and a combination thereof.
14 . The method of claim 13 , wherein the analyte is glucose.
15 . A method for normalizing opamp circuit gain in an LED-based fluorescence detecting sensor device comprising the steps of:
providing at least two LEDs that provide different intensities of 460 nm wavelength of light, wherein at least one LED is biased with about 5 mA of current, and at least one other LED is biased at 2.5 mA of current; alternating the power to the respective LEDs such that they are ON and OFF at different times; and acquiring analyte measurements with (i) the 5 mA LED ON, and 2.5 mA LED OFF, (ii) the 5 mA LED OFF, and 2.5 mA LED ON, and (iii) both the 5 mA LED ON and the 2.5 mA LED ON.Join the waitlist — get patent alerts
Track US2014275843A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.